Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Thumbnail

Eli Lilly caps insulin costs at $35 per month

The company announced price reductions of 70% for its most commonly prescribed insulins.

Medicare money payment physician

Hospitals still facing financial struggles in 2023

Hospital margins were -1% in January 2023, compared to -0.7% in December 2022. 

 

FDA authorizes first at-home flu and COVID-19 test

The test specifically can detect and differentiate between influenza A and B and the SARS-Cov-2 virus that causes COVID-19.

Emotional rescue: AI app interprets feelings of the nonverbal

A healthcare AI startup spawned from academia has launched an app to help caregivers understand the emotional state of individuals who are minimally verbal due to such conditions as autism, brain injury and dementia.

Pfizer in talks to acquire Seagen in deal worth more than $30B

Pharmaceutical giant Pfizer is reportedly in talks to acquire Seagen, a biotechnology company focused on developing cancer therapies.

artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google

AI in healthcare? Many patients seem unimpressed

60% of U.S. adults would be uncomfortable if their healthcare provider relied on AI for their medical care.

Sahil A. Parikh, MD, Director of Endovascular Services at Columbia University Irving Medical Center and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explained the growing trend or interventional cardiologists treating PAD and CLI. He shares what he thinks is important for cardiology departments to know before expanding expanding their programs in this space.

What do interventional cardiologists need to treat PAD and CLI?

Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 

CMS not changing ALZ drug restrictions

The announcement comes as more Alzheimer’s drugs are being evaluated with hopes that some new treatments could be breakthroughs.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup